Mark L Lipman Selected Research

MicroRNAs (MicroRNA)

1/2022	Distinct transcriptomic profile of small arteries of hypertensive patients with chronic kidney disease identified miR-338-3p targeting GPX3 and PTPRS.
1/2020	Circulating let-7g-5p and miR-191-5p Are Independent Predictors of Chronic Kidney Disease in Hypertensive Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark L Lipman Research Topics

Disease

4	Type 2 Diabetes Mellitus (MODY) 01/2021 - 04/2018
4	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 02/2014
4	Chronic Kidney Failure (Chronic Renal Failure) 11/2020 - 01/2008
3	Chronic Renal Insufficiency 01/2022 - 07/2007
3	Hypertension (High Blood Pressure) 01/2022 - 04/2013
2	Necrosis 01/2019 - 02/2014
2	Vascular Calcification 01/2018 - 08/2015
2	Atrial Fibrillation 01/2018 - 07/2017
1	Vascular System Injuries 01/2022
1	Vascular Remodeling 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2020
1	Cognitive Dysfunction 01/2019
1	Cough 04/2018
1	Angioedema 04/2018
1	Hemorrhage 01/2018
1	Hyperphosphatemia 01/2018
1	Stroke (Strokes) 07/2017
1	Hyperparathyroidism 08/2015
1	Delayed Graft Function 10/2014
1	Ischemia 10/2014
1	Colonic Neoplasms (Colon Cancer) 02/2014
1	Cyanosis 08/2010
1	Primary hyperoxaluria type 1 01/2008
1	Nephrolithiasis 01/2008
1	Atherosclerosis 07/2007
1	Hypersensitivity (Allergy) 04/2006

Drug/Important Bio-Agent (IBA)

2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2020
2	CanagliflozinIBA 01/2021 - 01/2019
2	Angiotensin Receptor AntagonistsIBA 01/2020 - 04/2018
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020 - 04/2018
2	Warfarin (Coumadin)FDA LinkGeneric 01/2018 - 07/2017
1	Messenger RNA (mRNA)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	SodiumIBA 01/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2019
1	TOR Serine-Threonine KinasesIBA 01/2018
1	Receptor for Advanced Glycation End ProductsIBA 01/2018
1	boldenone undecylenate (Equipoise)IBA 01/2018
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2018
1	apixabanIBA 07/2017
1	Pharmaceutical PreparationsIBA 07/2017
1	Dialysis SolutionsIBA 08/2015
1	MagnesiumIBA 08/2015
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2014
1	Erythropoietin FDA Link 04/2013
1	HematinicsIBA 04/2013
1	Calcium OxalateIBA 01/2008
1	OxalatesIBA 01/2008
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2007
1	Proteins (Proteins, Gene)FDA Link 04/2006

Therapy/Procedure

4	Renal Dialysis (Hemodialysis) 11/2020 - 08/2010
1	Kidney Transplantation 10/2014
1	Liver Transplantation 01/2008
1	Therapeutics 01/2008